Thyroid hormone analog, DITPA, improves endothelial nitric oxide and beta-adrenergic mediated vasorelaxation after myocardial infarction

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 4, 2004, Pages 453-459

  Spooner, Peter H ^a,b   Thai, Hoang M ^a,b   Goldman, Steven ^a,b,c   Gaballa, Mohamed A ^b  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Cardiology (I 111C)   (United States)

Author keywords

Beta adrenergic; Heart failure; Large artery; Nitric oxide; Thyroid hormone

Indexed keywords

3,5 DIIODOTHYROPROPIONIC ACID; ACETYLCHOLINE; ARGININE; BETA ADRENERGIC RECEPTOR; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; THYROID HORMONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ACETYLCHOLINE; ANIMALS; CATTLE; CELLS, CULTURED; CORONARY VESSELS; DIIODOTHYRONINES; ENDOTHELIUM, VASCULAR; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; ISOPROTERENOL; MYOCARDIAL INFARCTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 4644357380     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000140206.81804.33     Document Type: Article

References (29)

1. Kubo D, Rector T, Bank AJ, et al. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 1991;84:1589-1596.
2. Katz SD, Biasucci L, Sabba C, et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol. 1992;19:918-925.
3. Kiuchi K, Sato N, Shannon RP, et al. Depressed β-adrenergic receptor- and endothelium-mediated vasodilation in conscious dogs with heart failure. Circ Res. 1993;73:1013-1023.
4. Gaballa MA, Goldman S. Overexpression of endothelium nitric oxide synthase reverses the diminished vasorelaxation in the rat hindlimb in heart failure. J Mol Cell Cardiol. 1999;31:1243-1252.
5. Gaballa MA, Eckhart A, Koch WJ, et al. Vascular beta-adrenergic receptor system is dysfunctional after myocardial infarction. Am J Physiol. 2001;280:H1129-H1135.
6. Scivoletto R, Fortes BF, Garcia-Leme J. Thyroid hormones and vascular reactivity: role of the endothelial cell. Eur J Pharmacol. 1986;129:271-278.
7. Klein I. Thyroid hormone and the cardiovascular system. Am J Med. 1990; 88:631-637.
8. Park WP, Hai BD, Ojamaa K, et al. The Direct Vasomotor Effect of Thyroid Hormones on Rat Skeletal Muscle Resistance Arteries. Anesth Analg. 1997;85:734-738.
9. Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary artery bypass surgery. N Engl J Med. 1995;333:1522-1527.
10. Guerrero EB, Jimenez JL, White WD, et al. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. JAMA. 1996;275:687-692.
11. Hamilton MA, Stevenson LW, Fonarow GC, et al. Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heat failure. Am J Cardiol. 1998;81:443-447.
12. Malik FS, Mehra MR, Uber PA, et al. Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock. J Card Fail. 1999;5:31-37.
13. Pennock GD, Raya TE, Bahl JJ, et al. Cardiac effects of 3,5-diiodothyroproprionic acid, a thyroid analog with inotropic selectivity. J Pharmacol Exp Ther. 1992;263:163-169.
14. Pennock GD, Raya TE, Bahl JJ, et al. Combination treatment with captopril and the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA): A new approach to improving left ventricular performance in heart failure. Circulation. 1993;88:1289-1298.
15. Mahaffey K, Raya TE, Pennock G, et al. Ventricular performance and remodeling in rabbits after myocardial infarction: Effects of a thyroid hormone analogue. Circulation. 1995;91:794-802.
16. Pennock GD, Spooner PH, Summers CE, et al. Prevention of abnormal sarcoplasmic reticulum calcium transport and protein expression in postinfarction heart failure using 3,5-diiodothyropropionic acid. J Mol Cell Cardiol. 2000;32:1939-1953.
17. Spooner PH, Morkin E, Goldman S. Thyroid hormone and thyroid hormone analogues in the treatment of heart failure. Coron Artery Dis. 1999; 10:395-399.
18. Morkin E, Pennock G, Spooner PH, et al. Preliminary studies on the use of 3,5-diiodothyroproprionic acid, a thyroid analog, in the treatment of congestive heart failure. Cardiology. 2002;97:218-225.
19. Gaballa MA, Goldman S. Cross talk between vascular endothelial beta-adrenergic and nitric oxide pathways. J Card Fail. 2000;6:3, 31.
20. Goldman S, Raya TE. Rat infarct model of myocardial infarction and heart failure. J Card Fail. 1995;1:169-175.
21. 2-adrenergic receptors in large arteries. J Mol Cell Cardiol. 1998;30:1037-1045.
22. Bates K, Ruggeroli CE, Goldman S, et al. Simvastatin restores endothelial nitric oxide mediated vasorelaxation in large arteries after myocardial infarction. Am J Physiol. 2002;283:H768-H775.
23. Gaballa MA, Goldman S. Ventricular remodeling in heart failure. J Card Fail. 2002;8:S476-S485.
24. 3-adrenergic receptor activation. J Card Fail. 2003;9, 5:S66.
25. Oriowo MA. Atypical β-adrenoceptors in the rat isolated common carotid artery. Br J Pharmacol. 1994;113:699-702.
26. Oriowo MA. Different atypical β-adrenoceptors mediate isoprenaline-induced relaxation in vascular and non-vascular smooth muscles. Life Sci. 1995;0:PL269-PL275.
27. Sooch S, Marshall I. Atypical β-adrenoceptors in the rat vasculature. Ann NY Acad Sci. 1997;812:211-212.
28. Trochu J-N, Leblais V, Rautureau Y, et al. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br J Pharmacol. 1999;128:69-76.
29. Litwin SE, Zhang D, Roberge P, et al. DITPA prevents the blunted contraction-frequency relationship in myocytes from infarcted hearts. Am J Physiol. 2000;278:H862-H870.